<?xml version='1.0' encoding='utf-8'?>
<document id="24530518"><sentence text="Methotrexate-bestatin interaction: involvement of P-glycoprotein and organic anion transporters in rats."><entity charOffset="0-12" id="DDI-PubMed.24530518.s1.e0" text="Methotrexate" /><entity charOffset="13-21" id="DDI-PubMed.24530518.s1.e1" text="bestatin" /><pair ddi="false" e1="DDI-PubMed.24530518.s1.e0" e2="DDI-PubMed.24530518.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24530518.s1.e0" e2="DDI-PubMed.24530518.s1.e1" /></sentence><sentence text="To clarify the pharmacokinetic interaction and its possible mechanism, mutual effects between methotrexate (MTX) and bestatin in oral absorption and renal excretion in rats were examined in vivo and in vitro"><entity charOffset="94-106" id="DDI-PubMed.24530518.s2.e0" text="methotrexate" /><entity charOffset="108-111" id="DDI-PubMed.24530518.s2.e1" text="MTX" /><entity charOffset="117-125" id="DDI-PubMed.24530518.s2.e2" text="bestatin" /><pair ddi="false" e1="DDI-PubMed.24530518.s2.e0" e2="DDI-PubMed.24530518.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24530518.s2.e0" e2="DDI-PubMed.24530518.s2.e1" /><pair ddi="false" e1="DDI-PubMed.24530518.s2.e0" e2="DDI-PubMed.24530518.s2.e2" /><pair ddi="false" e1="DDI-PubMed.24530518.s2.e1" e2="DDI-PubMed.24530518.s2.e1" /><pair ddi="false" e1="DDI-PubMed.24530518.s2.e1" e2="DDI-PubMed.24530518.s2.e2" /></sentence><sentence text=" A sensitive, quick and high performance method (LC-MS/MS) was used to determine concentrations of MTX and bestatin in biological samples"><entity charOffset="99-102" id="DDI-PubMed.24530518.s3.e0" text="MTX" /><entity charOffset="107-115" id="DDI-PubMed.24530518.s3.e1" text="bestatin" /><pair ddi="false" e1="DDI-PubMed.24530518.s3.e0" e2="DDI-PubMed.24530518.s3.e0" /><pair ddi="false" e1="DDI-PubMed.24530518.s3.e0" e2="DDI-PubMed.24530518.s3.e1" /></sentence><sentence text=" Plasma concentrations of MTX and bestatin markedly increased following oral and intravenous administration of MTX in combination with bestatin"><entity charOffset="26-29" id="DDI-PubMed.24530518.s4.e0" text="MTX" /><entity charOffset="34-42" id="DDI-PubMed.24530518.s4.e1" text="bestatin" /><entity charOffset="111-114" id="DDI-PubMed.24530518.s4.e2" text="MTX" /><entity charOffset="135-143" id="DDI-PubMed.24530518.s4.e3" text="bestatin" /><pair ddi="false" e1="DDI-PubMed.24530518.s4.e0" e2="DDI-PubMed.24530518.s4.e0" /><pair ddi="false" e1="DDI-PubMed.24530518.s4.e0" e2="DDI-PubMed.24530518.s4.e1" /><pair ddi="false" e1="DDI-PubMed.24530518.s4.e0" e2="DDI-PubMed.24530518.s4.e2" /><pair ddi="false" e1="DDI-PubMed.24530518.s4.e0" e2="DDI-PubMed.24530518.s4.e3" /><pair ddi="false" e1="DDI-PubMed.24530518.s4.e1" e2="DDI-PubMed.24530518.s4.e1" /><pair ddi="false" e1="DDI-PubMed.24530518.s4.e1" e2="DDI-PubMed.24530518.s4.e2" /><pair ddi="false" e1="DDI-PubMed.24530518.s4.e1" e2="DDI-PubMed.24530518.s4.e3" /><pair ddi="false" e1="DDI-PubMed.24530518.s4.e2" e2="DDI-PubMed.24530518.s4.e2" /><pair ddi="false" e1="DDI-PubMed.24530518.s4.e2" e2="DDI-PubMed.24530518.s4.e3" /></sentence><sentence text=" The cumulative urinary excretion and renal clearance of the two drugs significantly decreased when MTX and bestatin were co-administered intravenously"><entity charOffset="100-103" id="DDI-PubMed.24530518.s5.e0" text="MTX" /><entity charOffset="108-116" id="DDI-PubMed.24530518.s5.e1" text="bestatin" /><pair ddi="false" e1="DDI-PubMed.24530518.s5.e0" e2="DDI-PubMed.24530518.s5.e0" /><pair ddi="false" e1="DDI-PubMed.24530518.s5.e0" e2="DDI-PubMed.24530518.s5.e1" /></sentence><sentence text=" Uptake of the two drugs in in situ single-pass intestinal perfusion studies and in vitro everted intestinal sac preparations significantly increased when co-administered, while uptake in rat kidney slices and hOAT1- or hOAT3-HEK 293 cells significantly decreased" /><sentence text=" Transport rates of bestatin and MTX from basolateral-to-apical transepithelial transport in MDR1-MDCK cells significantly decreased following co-administration"><entity charOffset="20-28" id="DDI-PubMed.24530518.s7.e0" text="bestatin" /><entity charOffset="33-36" id="DDI-PubMed.24530518.s7.e1" text="MTX" /><pair ddi="false" e1="DDI-PubMed.24530518.s7.e0" e2="DDI-PubMed.24530518.s7.e0" /><pair ddi="false" e1="DDI-PubMed.24530518.s7.e0" e2="DDI-PubMed.24530518.s7.e1" /></sentence><sentence text=" Additionally, intracellular concentrations increased, and the efflux transport of the two drugs was inhibited when given together" /><sentence text=" The IC₅₀ values of MTX and bestatin in K562 and K562/ADR cells decreased when the two were co-administered"><entity charOffset="20-23" id="DDI-PubMed.24530518.s9.e0" text="MTX" /><entity charOffset="28-36" id="DDI-PubMed.24530518.s9.e1" text="bestatin" /><pair ddi="false" e1="DDI-PubMed.24530518.s9.e0" e2="DDI-PubMed.24530518.s9.e0" /><pair ddi="false" e1="DDI-PubMed.24530518.s9.e0" e2="DDI-PubMed.24530518.s9.e1" /></sentence><sentence text=" These findings indicate that the pharmacokinetic mechanism of interaction between MTX and bestatin occurs through co-transport by P-gp in the intestinal mucosa and OATs within the kidneys"><entity charOffset="91-99" id="DDI-PubMed.24530518.s10.e0" text="bestatin" /><entity charOffset="83-90" id="DDI-PubMed.24530518.s10.e1" text="MTX" /><pair ddi="false" e1="DDI-PubMed.24530518.s10.e1" e2="DDI-PubMed.24530518.s10.e1" /><pair ddi="false" e1="DDI-PubMed.24530518.s10.e1" e2="DDI-PubMed.24530518.s10.e0" /></sentence><sentence text="" /></document>